Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167582 · ClinicalTrials.gov registry record · Phase 3
Myocardial Ischemia and Transfusion Pilot
A Phase 3 study of Coronary Artery Disease and Myocardial Infarction, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 110
- Enrollment target
- 7
- Study locations
NCT01167582: Completed Phase 3 study of Coronary Artery Disease and Myocardial Infarction, sponsored by Rutgers, The State University of New Jersey.
NCT01167582 is a Phase 3 study of Coronary Artery Disease and Myocardial Infarction that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 110 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (91% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01167582, a Phase 3 study of Coronary Artery Disease and Myocardial Infarction, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 110 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to evaluate two approaches to red blood cell transfusion in anemic patients with acute coronary syndrome.
Primary Outcome
Differences in the mean hemoglobin concentrations between the two study arms.
Conditions Studied
Interventions
- BIOLOGICAL Red blood cell transfusion
Study Locations (7)
New York
- Jack D. Weiler Hospital of Montefiore Medical Center - New York
- Montefiore Medical Center - The Bronx
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
- University of Pittsburgh Data Coordinating Center - Pittsburgh
Massachusetts
- Brigham and Women's Hospital - Boston
New Jersey
- Robert Wood Johnson University Hospital - New Brunswick
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
What the finished NCT01167582 record still lists
NCT01167582 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Red blood cell transfusion is the first listed.
NCT01167582 lists 7 locations in 5 states (New York, Pennsylvania, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT01167582 about?
NCT01167582 is a clinical study titled "Myocardial Ischemia and Transfusion Pilot". The purpose of this study is to evaluate two approaches to red blood cell transfusion in anemic patients with acute coronary syndrome.
What is the current status of trial NCT01167582?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 110 participants. The study started on 2009-09. Estimated completion is 2012-06.
What conditions does trial NCT01167582 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Infarction, Unstable Angina.
What interventions are being tested in trial NCT01167582?
The interventions under investigation include: Red blood cell transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT01167582?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01167582 being conducted?
This trial has 7 study locations across Massachusetts, New Jersey, New York, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01167582's enrollment target sits among peer trials
110 141st of 219 higher than 78 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
RECRUITING · Phase 3
-
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
RECRUITING · Phase 3
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
RECRUITING · Phase 3
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
RECRUITING · Phase 3
-
PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients
ACTIVE NOT RECRUITING · Phase 3
-
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia